Paclitaxel in the Treatment of Carcinosarcoma of the Uterus: A Gynecologic Oncology Group Study

Objective. The goal of this study was to estimate the clinical activity of paclitaxel in patients with persistent or recurrent carcinosarcoma of the uterus who have failed other treatments. Methods. The Gynecologic Oncology Group (GOG) conducted a phase II study of paclitaxel 170 mg/m2 (135 mg/m2 in...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Gynecologic oncology Ročník 83; číslo 2; s. 268 - 270
Hlavní autori:	Curtin, John P., Blessing, John A., Soper, John T., DeGeest, Koen
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	San Diego, CA Elsevier Inc 01.11.2001 Elsevier
Predmet:	Adult Aged Antineoplastic Agents, Phytogenic - adverse effects Antineoplastic Agents, Phytogenic - therapeutic use Biological and medical sciences Carcinosarcoma - drug therapy Drug Administration Schedule Female Female genital diseases Gynecology. Andrology. Obstetrics Humans Infusions, Intravenous Medical sciences Middle Aged Neoplasm Recurrence, Local - drug therapy Paclitaxel - adverse effects Paclitaxel - therapeutic use Tumors Uterine Neoplasms - drug therapy Human Antineoplastic agent Relapse Treatment resistance Treatment efficiency Malignant tumor Female genital diseases Chemotherapy Treatment Uterus Taxane derivatives Paclitaxel Uterine diseases Adult Female Spindle cell carcinoma
ISSN:	0090-8258, 1095-6859
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!